Novel Nanomedicines for Cancer Therapy
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (30 November 2023) | Viewed by 2893
Special Issue Editors
Interests: nano-bio interaction; nanozyme; nanocatalytic medicine; tumor radiotherapy
Interests: biomaterials; nanomedicine; tumor therapy; immunotherapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cancer remains a leading cause of mortality worldwide, and has become a major global public health issue. In recent years, rapid progress in novel nanomaterials and nanomedicines has demonstrated great promise in improving the therapeutic outcomes relating to cancer. Nanomedicines can not only be designed as drug delivery systems, but also possess unique physicochemical properties, which can be activated by external excitations such as near-infrared light, X-rays, ultrasound, and magnetic fields, and trigger tumor microenvironment-responsive nanocatalytic reactions in the tumor region to achieve enhanced anti-cancer efficacy.
In this Special Issue, we aim to cover the latest research on multifunctional nanomaterials and novel nanomedicines for cancer therapy. We cordially welcome investigators to submit articles to this Special Issue (original research, review, and perspective articles). Topics will include (but are not limited to):
- Nano-drug delivery systems for cancer therapy;
- Functional nanomaterials activated by external excitations such as near-infrared light, X-ray, ultrasound, and magnetic fields;
- Nanomedicine with tumor microenvironment-responsive nanocatalytic therapy
Dr. Yu Chong
Dr. Yu Luo
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanomaterials-based drug delivery
- nanocatalytic medicine
- immune modulatable nanomedicine
- nano-radiosensitizer
- nanozyme
- tumor microenvironment
- photodynamic therapy
